Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Suma Krishnan. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Suma Krishnan telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:KRYS / Krystal Biotech, Inc. President, R&D, Director, 10% Owner 1,508,056
US:XON / Intrexon Corp. SVP--Product Development 30,591
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Suma Krishnan. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam KRYS / Krystal Biotech, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam KRYS / Krystal Biotech, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2018-10-18 KRYS Krishnan Suma 25,000 20.0000 25,000 20.0000 500,000 277 51.3000 782,500 156.50
2018-06-06 KRYS Krishnan Suma 13,116 11.1450 13,116 11.1450 146,178
2018-06-06 KRYS Krishnan Suma 1,018 12.4500 1,018 12.4500 12,674
2018-06-05 KRYS Krishnan Suma 10,866 10.7452 10,866 10.7452 116,757

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

KRYS / Krystal Biotech, Inc. Insider Trades
Jualan Orang Dalam KRYS / Krystal Biotech, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam KRYS / Krystal Biotech, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2023-05-31 KRYS Krishnan Suma 20,143 115.9757 20,143 115.9757 2,336,099 162 96.0000 -402,370 -17.22
2023-05-31 KRYS Krishnan Suma 4,557 116.8624 4,557 116.8624 532,542
2023-05-31 KRYS Krishnan Suma 300 117.5733 300 117.5733 35,272
2023-05-31 KRYS Krishnan Suma 18,884 115.9950 18,884 115.9950 2,190,450
2023-05-31 KRYS Krishnan Suma 5,716 116.9498 5,716 116.9498 668,485
2023-05-31 KRYS Krishnan Suma 400 117.6050 400 117.6050 47,042
2021-12-10 KRYS Krishnan Suma 100,000 70.5000 100,000 70.5000 7,050,000

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

KRYS / Krystal Biotech, Inc. Insider Trades
Pembelian Orang Dalam PGEN / Precigen, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam KRYS / Krystal Biotech, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
2014-05-09 XON Krishnan Suma 20,900 14.2116 20,900 14.2116 297,022 731

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

PGEN / Precigen, Inc. Insider Trades
Jualan Orang Dalam PGEN / Precigen, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam KRYS / Krystal Biotech, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2015-12-04 XON Krishnan Suma 900 30.1233 900 30.1233 27,111 228
2015-12-02 XON Krishnan Suma 20,000 35.9130 20,000 35.9130 718,260

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

PGEN / Precigen, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Suma Krishnan seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2025-07-16 2025-07-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,389 1,508,056 -0.09 150.00 -208,350 226,208,400
2025-07-16 2025-07-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,529 1,438,711 -0.11 150.00 -229,350 215,806,650
2025-07-16 2025-07-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -900 1,509,445 -0.06 151.79 -136,611 229,118,657
2025-07-16 2025-07-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,184 1,510,345 -0.14 150.68 -329,089 227,581,352
2025-07-16 2025-07-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -800 1,440,240 -0.06 151.79 -121,432 218,614,030
2025-07-16 2025-07-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,236 1,441,040 -0.15 150.68 -336,929 217,141,527
2025-07-16 2025-07-14 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -13,400 1,512,529 -0.88 150.30 -2,014,015 227,332,504
2025-07-16 2025-07-14 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -100 1,443,276 -0.01 151.00 -15,100 217,934,676
2025-07-16 2025-07-14 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -13,335 1,443,376 -0.92 150.29 -2,004,125 216,925,845
2025-07-11 2025-07-10 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -300 1,525,929 -0.02 151.39 -45,416 231,005,356
2025-07-11 2025-07-10 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -300 1,525,929 -0.02 151.39 -45,416 231,005,356
2025-07-11 2025-07-10 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,627 1,526,229 -0.43 150.22 -995,497 229,267,678
2025-07-11 2025-07-10 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,500 1,457,011 -0.44 150.23 -976,464 218,879,769
2025-07-11 2025-07-09 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -200 1,532,856 -0.01 150.07 -30,014 230,035,700
2025-07-11 2025-07-09 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -200 1,463,511 -0.01 150.14 -30,028 219,730,078
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,256 1,533,056 -0.08 179.57 -225,544 275,296,232
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,769 1,534,312 -0.44 178.77 -1,210,077 274,284,967
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,931 1,541,081 -0.70 177.62 -1,941,611 273,733,434
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,944 1,552,012 -0.32 176.80 -874,123 274,403,171
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,100 1,556,956 -0.07 175.83 -193,408 273,752,723
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,331 1,463,711 -0.09 179.55 -238,977 262,804,333
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,514 1,465,042 -0.44 178.76 -1,164,415 261,884,755
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,937 1,471,556 -0.74 177.66 -1,943,027 261,431,194
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,579 1,482,493 -0.31 176.88 -809,924 262,220,249
2025-03-13 2025-03-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,639 1,487,072 -0.11 175.97 -288,419 261,683,629
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -12,149 1,562,777 -0.77 179.25 -2,177,708 280,127,777
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 26,250 1,574,926 1.69
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -4,050 1,548,676 -0.26 179.25 -725,962 277,600,173
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 8,750 1,552,726 0.57
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -5,786 1,543,976 -0.37 179.25 -1,037,140 276,757,698
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 12,500 1,549,762 0.81
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -10,414 1,488,711 -0.69 179.25 -1,866,710 266,851,447
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 22,500 1,499,125 1.52
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -3,471 1,476,625 -0.23 179.25 -622,177 264,685,031
2025-02-28 2025-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 7,500 1,480,096 0.51
2025-02-28 2025-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -4,721 1,558,056 -0.30 176.39 -832,737 274,825,498
2025-02-28 2025-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -3,286 1,472,596 -0.22 176.39 -579,618 259,751,208
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -640 1,537,262 -0.04 171.63 -109,842 263,838,432
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -957 1,537,902 -0.06 170.47 -163,139 262,164,155
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -911 1,538,859 -0.06 169.65 -154,550 261,064,967
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -923 1,539,770 -0.06 166.93 -154,074 257,029,803
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,977 1,540,693 -0.13 165.82 -327,833 255,483,106
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,909 1,542,670 -0.32 164.93 -809,644 254,433,489
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,381 1,547,579 -0.54 163.91 -1,373,756 253,668,471
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,302 1,555,960 -0.40 163.07 -1,027,661 253,728,841
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -620 1,475,882 -0.04 171.62 -106,407 253,297,510
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -727 1,476,502 -0.05 170.43 -123,903 251,640,679
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -953 1,477,229 -0.06 169.48 -161,515 250,361,066
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -200 1,478,182 -0.01 168.31 -33,662 248,793,256
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -798 1,478,382 -0.05 166.96 -133,233 246,827,998
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,114 1,479,180 -0.14 165.79 -350,490 245,240,204
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,723 1,481,294 -0.32 164.92 -778,894 244,287,600
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,923 1,486,017 -0.60 163.92 -1,462,617 243,581,071
2024-12-13 2024-12-13 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,942 1,494,940 -0.40 163.04 -968,804 243,740,250
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -800 1,562,262 -0.05 201.81 -161,447 315,277,751
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,395 1,563,062 -0.15 200.98 -481,337 314,137,636
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,600 1,565,457 -0.23 200.15 -720,548 313,329,663
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,008 1,569,057 -0.25 198.93 -797,297 312,126,860
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,086 1,573,065 -0.13 198.08 -413,196 311,593,187
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,696 1,575,151 -0.11 197.04 -334,178 310,365,705
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,458 1,576,847 -0.41 195.72 -1,263,977 308,624,595
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,957 1,583,305 -0.25 195.16 -772,259 309,002,079
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,895 1,500,882 -0.13 201.52 -381,876 302,454,289
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,159 1,502,777 -0.28 200.41 -833,526 301,178,902
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,945 1,506,936 -0.20 199.22 -586,712 300,216,461
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,392 1,509,881 -0.22 198.43 -673,085 299,610,216
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,385 1,513,273 -0.09 197.55 -273,600 298,940,120
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,727 1,514,658 -0.18 196.07 -534,674 296,974,147
2024-09-13 2024-09-12 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,497 1,517,385 -0.56 195.43 -1,660,566 296,542,095
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -998 1,587,262 -0.06 178.36 -178,000 283,098,336
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,447 1,588,260 -0.34 177.68 -967,814 282,199,496
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,705 1,593,707 -0.36 176.68 -1,007,951 281,573,922
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,550 1,599,412 -0.28 175.76 -799,693 281,107,535
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,000 1,603,962 -0.25 174.83 -699,304 280,414,421
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,318 1,607,962 -0.08 173.49 -228,657 278,961,307
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,882 1,609,280 -0.12 172.21 -324,104 277,138,615
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,100 1,611,162 -0.07 171.49 -188,637 276,294,949
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,871 1,525,882 -0.12 178.14 -333,309 271,827,791
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,358 1,527,753 -0.41 177.38 -1,127,773 270,990,536
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,867 1,534,111 -0.38 176.38 -1,034,792 270,578,828
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,975 1,539,978 -0.32 175.33 -872,273 270,006,345
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,724 1,544,953 -0.11 174.50 -300,831 269,588,428
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,206 1,546,677 -0.08 173.41 -209,137 268,215,445
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,099 1,547,883 -0.14 172.24 -361,529 266,605,046
2024-06-11 2024-06-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -900 1,549,982 -0.06 171.40 -154,257 265,661,025
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,314 1,612,262 -0.08 174.00 -228,631 280,526,978
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,359 1,613,576 -0.21 173.09 -581,402 279,290,481
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,816 1,616,935 -0.17 172.06 -484,519 278,208,704
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,002 1,619,751 -0.49 170.93 -1,367,770 276,861,609
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,109 1,627,753 -0.31 170.32 -870,186 277,245,565
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,254 1,632,862 -0.14 168.88 -380,660 275,761,327
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,146 1,635,116 -0.13 167.99 -360,511 274,686,734
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -800 1,550,882 -0.05 174.13 -139,305 270,057,099
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,587 1,551,682 -0.23 173.30 -621,624 268,905,094
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,800 1,555,269 -0.18 172.21 -482,176 267,826,187
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,469 1,558,069 -0.35 171.09 -935,713 266,576,102
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,040 1,563,538 -0.51 170.42 -1,370,174 266,457,521
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,646 1,571,578 -0.10 168.96 -278,104 265,529,733
2024-03-11 2024-03-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,658 1,573,224 -0.17 168.15 -446,945 264,538,874
2024-03-01 2024-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -5,785 1,637,262 -0.35 163.08 -943,418 267,004,687
2024-03-01 2024-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 12,500 1,643,047 0.77
2024-03-01 2024-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -3,471 1,575,882 -0.22 163.08 -566,051 256,994,837
2024-03-01 2024-02-28 4 KRYS Krystal Biotech, Inc.
Common Stock
M - Exercise 7,500 1,579,353 0.48
2024-02-28 2024-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -2,353 1,571,853 -0.15 157.00 -369,421 246,780,921
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -100 1,634,338 -0.01 107.66 -10,766 175,952,829
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -100 1,634,338 -0.01 107.66 -10,766 175,952,829
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -14,237 1,634,438 -0.86 106.11 -1,510,667 173,427,765
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -6,263 1,648,675 -0.38 105.50 -660,771 173,941,642
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,400 1,654,938 -0.27 104.41 -459,424 172,799,689
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -17,505 1,574,306 -1.10 106.04 -1,856,241 166,940,353
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,541 1,591,811 -0.28 105.06 -477,087 167,239,006
2023-12-12 2023-12-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,854 1,596,352 -0.18 104.26 -297,569 166,441,885
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,110 1,659,338 -0.13 129.10 -272,404 214,222,693
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,557 1,661,448 -0.63 128.37 -1,355,216 213,282,240
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,557 1,661,448 -0.63 128.37 -1,355,216 213,282,240
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,873 1,672,005 -0.11 127.18 -238,214 212,650,946
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,452 1,673,878 -0.32 126.17 -687,866 211,189,337
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,008 1,679,330 -0.30 125.23 -627,139 210,298,298
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,110 1,599,206 -0.13 129.10 -272,404 206,459,733
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,874 1,611,873 -0.12 127.18 -238,342 205,003,327
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,452 1,613,747 -0.34 126.17 -687,866 203,602,586
2023-09-12 2023-09-11 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,007 1,619,199 -0.31 125.23 -627,014 202,768,243
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -400 1,684,338 -0.02 117.60 -47,042 198,086,570
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -5,716 1,684,738 -0.34 116.95 -668,485 197,029,772
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -18,884 1,690,454 -1.10 116.00 -2,190,450 196,084,212
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -300 1,624,206 -0.02 117.57 -35,272 190,963,259
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -4,557 1,624,506 -0.28 116.86 -532,542 189,843,670
2023-06-02 2023-05-31 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -20,143 1,629,063 -1.22 115.98 -2,336,099 188,931,722
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -500 1,713,688 -0.03 89.12 -44,559 152,719,590
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -500 1,713,688 -0.03 89.12 -44,559 152,719,590
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,724 1,714,188 -0.56 88.41 -859,662 151,544,847
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,724 1,714,188 -0.56 88.41 -859,662 151,544,847
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,428 1,723,912 -0.54 87.41 -824,114 150,689,389
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,298 1,733,340 -0.25 86.80 -373,051 150,447,672
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,050 1,737,638 -0.06 85.55 -89,826 148,651,977
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,429 1,659,430 -0.56 87.41 -824,202 145,053,100
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4,297 1,668,859 -0.26 86.80 -372,964 144,850,953
2023-04-18 2023-04-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,050 1,673,156 -0.06 85.55 -89,826 143,136,321
2023-02-28 2023-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -3,057 1,674,206 -0.18 78.46 -239,852 131,358,203
2023-01-19 2023-01-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -803 1,738,688 -0.05 81.56 -65,492 141,806,002
2023-01-19 2023-01-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,048 1,739,491 -0.12 80.75 -165,382 140,469,291
2023-01-19 2023-01-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -804 1,677,263 -0.05 81.56 -65,574 136,796,228
2023-01-19 2023-01-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,048 1,678,067 -0.12 80.75 -165,382 135,508,441
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -346 1,741,539 -0.02 82.71 -28,619 144,050,353
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,186 1,741,885 -0.07 81.41 -96,548 141,800,239
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -20,617 1,743,071 -1.17 80.70 -1,663,831 140,669,142
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -20,617 1,743,071 -1.17 80.70 -1,663,831 140,669,142
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -345 1,680,115 -0.02 82.72 -28,537 138,971,216
2023-01-19 2023-01-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,186 1,680,460 -0.07 81.41 -96,548 136,800,703
2023-01-05 2023-01-04 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,748 1,763,688 -0.21 80.08 -300,140 141,236,311
2023-01-05 2023-01-04 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -3,938 1,702,263 -0.23 80.09 -315,385 136,330,158
2023-01-03 2023-01-03 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,700 1,767,436 -0.10 80.33 -136,567 141,984,320
2023-01-03 2023-01-03 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,700 1,706,201 -0.10 80.33 -136,554 137,052,302
2023-01-03 2022-12-29 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -563 1,769,136 -0.03 81.11 -45,662 143,486,660
2023-01-03 2022-12-29 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,447 1,769,699 -0.42 80.28 -597,849 142,072,321
2023-01-03 2022-12-29 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -528 1,707,901 -0.03 81.10 -42,822 138,514,187
2023-01-03 2022-12-29 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,484 1,708,429 -0.44 80.30 -600,957 137,184,969
2022-12-20 2022-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,572 1,777,146 -0.59 80.10 -846,816 142,349,217
2022-12-20 2022-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,527 1,715,913 -0.61 80.10 -843,170 137,437,596
2022-11-28 2022-11-23 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4 1,787,718 0.00 80.01 -320 143,035,317
2022-11-10 2022-11-08 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -966 1,787,722 -0.05 80.05 -77,331 143,111,258
2022-11-10 2022-11-08 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -823 1,726,440 -0.05 80.04 -65,871 138,179,596
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,854 1,788,688 -0.16 82.19 -234,576 147,015,665
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -13,058 1,791,542 -0.72 81.61 -1,065,639 146,204,339
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,088 1,804,600 -0.50 80.24 -729,208 144,798,578
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,576 1,727,263 -0.15 82.20 -211,755 141,986,200
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -13,432 1,729,839 -0.77 81.62 -1,096,316 141,188,940
2022-08-09 2022-08-05 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,992 1,743,271 -0.51 80.22 -721,332 139,843,979
2022-03-01 2022-02-28 4 KRYS Krystal Biotech, Inc.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2022-03-01 2022-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
F - Taxes -3,282 1,752,263 -0.19 62.50 -205,125 109,516,438
2021-12-14 2021-12-10 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale -100,000 50,000 -66.67 70.50 -7,050,000 3,525,000
2021-03-02 2021-02-26 4 KRYS Krystal Biotech, Inc.
Stock Option (Right to Buy)
A - Award 42,600 42,600
2021-03-02 2021-02-26 4 KRYS Krystal Biotech, Inc.
Common Stock
A - Award 28,400 1,864,464 1.55
2020-09-17 2020-09-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,126 1,836,064 -0.06 47.29 -53,248 86,827,099
2020-09-17 2020-09-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,437 1,837,190 -0.40 46.63 -346,813 85,674,600
2020-09-17 2020-09-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,594 1,844,627 -0.57 46.09 -488,297 85,022,179
2020-09-17 2020-09-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,142 1,855,221 -0.28 46.85 -240,896 86,914,507
2020-09-17 2020-09-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -9,749 1,860,363 -0.52 46.24 -450,821 86,028,394
2020-09-17 2020-09-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,517 1,870,112 -0.08 47.15 -71,523 88,171,667
2020-09-17 2020-09-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -14,435 1,871,629 -0.77 46.21 -667,031 86,486,666
2020-06-17 2020-06-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -11,719 1,886,064 -0.62 45.07 -528,182 85,006,036
2020-06-17 2020-06-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -11,311 1,897,783 -0.59 44.56 -504,058 84,571,853
2020-06-17 2020-06-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,740 1,909,094 -0.56 43.21 -464,070 82,490,997
2020-06-17 2020-06-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,652 1,919,834 -0.45 42.24 -365,427 81,086,301
2020-06-17 2020-06-15 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,578 1,928,486 -0.39 41.31 -313,038 79,663,442
2020-03-18 2020-03-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -659 1,936,064 -0.03 40.20 -26,493 77,833,258
2020-03-18 2020-03-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -4 1,936,723 0.00 42.03 -168 81,400,468
2020-03-18 2020-03-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,396 1,936,727 -0.07 41.27 -57,607 79,920,589
2020-03-18 2020-03-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -10,780 1,938,123 -0.55 40.49 -436,429 78,465,103
2020-03-18 2020-03-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -2,559 1,948,903 -0.13 40.14 -102,714 78,225,848
2019-12-18 2019-12-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -239 1,951,462 -0.01 63.31 -15,132 123,555,451
2019-12-18 2019-12-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,756 1,951,701 -0.29 62.65 -360,592 122,266,846
2019-12-18 2019-12-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -900 1,957,457 -0.05 61.28 -55,153 119,955,118
2019-12-18 2019-12-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,017 1,958,357 -0.05 60.19 -61,215 117,877,620
2019-12-18 2019-12-18 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,200 1,959,374 -0.06 59.49 -71,387 116,561,788
2019-12-18 2019-12-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -279 1,960,574 -0.01 63.35 -17,674 124,196,873
2019-12-18 2019-12-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -1,834 1,960,853 -0.09 62.79 -115,158 123,123,332
2019-12-18 2019-12-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -891 1,962,687 -0.05 61.72 -54,994 121,141,360
2019-12-18 2019-12-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,799 1,963,578 -0.45 60.46 -531,996 118,719,889
2019-12-18 2019-12-17 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -8,138 1,972,377 -0.41 59.87 -487,203 118,081,477
2019-12-18 2019-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -322 1,980,515 -0.02 65.60 -21,125 129,930,102
2019-12-18 2019-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -5,856 1,980,837 -0.29 64.28 -376,413 127,324,637
2019-12-18 2019-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,396 1,986,693 -0.37 63.62 -470,559 126,400,362
2019-12-18 2019-12-16 4 KRYS Krystal Biotech, Inc.
Common Stock
S - Sale X -7,373 1,994,089 -0.37 62.84 -463,352 125,317,327
2018-10-22 2018-10-18 4 KRYS Krystal Biotech, Inc.
Common Stock
P - Purchase 25,000 2,001,462 1.26 20.00 500,000 40,029,240
2018-06-07 2018-06-06 4 KRYS Krystal Biotech, Inc.
Common Stock
P - Purchase 1,018 1,976,462 0.05 12.45 12,674 24,606,952
2018-06-07 2018-06-06 4 KRYS Krystal Biotech, Inc.
Common Stock
P - Purchase 13,116 1,975,444 0.67 11.14 146,178 22,016,323
2018-06-07 2018-06-05 4 KRYS Krystal Biotech, Inc.
Common Stock
P - Purchase 10,866 1,962,328 0.56 10.75 116,757 21,085,607
2018-06-05 2018-06-01 4 KRYS Krystal Biotech, Inc.
Common Stock
J - Other 16,213 1,951,462 0.84
2017-09-25 2017-09-22 4 KRYS Krystal Biotech, Inc.
Series A Convertible Preferred Stock
C - Conversion -112,162 0 -100.00
2017-09-25 2017-09-22 4 KRYS Krystal Biotech, Inc.
Common Stock
C - Conversion 112,162 112,162
2017-09-25 2017-09-22 4 KRYS Krystal Biotech, Inc.
Common Stock
P - Purchase 100,000 1,935,249 5.45 10.00 1,000,000 19,352,490
2017-09-19 3 KRYS Krystal Biotech, Inc.
Common Stock
5,617,909
2017-09-19 3 KRYS Krystal Biotech, Inc.
Common Stock
5,617,909
2017-09-19 3 KRYS Krystal Biotech, Inc.
Series A Convertible Preferred Stock
3,894,822
2017-09-19 3 KRYS Krystal Biotech, Inc.
Common Stock
5,617,909
2017-09-19 3 KRYS Krystal Biotech, Inc.
Common Stock
5,617,909
2017-09-19 3 KRYS Krystal Biotech, Inc.
Series A Convertible Preferred Stock
3,894,822
2016-02-01 2016-01-29 4 XON INTREXON CORP
Option to Purchase Common Stock (Right to Buy)
M - Exercise -14,657 30,591 -32.39
2016-02-01 2016-01-29 4 XON INTREXON CORP
Common Stock
M - Exercise 14,657 56,657 34.90 6.88 100,840 389,800
2016-02-01 2016-01-28 4 XON INTREXON CORP
Option to Purchase Common Stock (Right to Buy)
M - Exercise -14,657 533,362 -2.67
2016-02-01 2016-01-28 4 XON INTREXON CORP
Common Stock
M - Exercise 14,657 56,657 34.90 6.88 100,840 389,800
2015-12-04 2015-12-04 4 XON INTREXON CORP
Common Stock
S - Sale -900 42,000 -2.10 30.12 -27,111 1,265,179
2015-12-04 2015-12-02 4 XON INTREXON CORP
Common Stock
S - Sale -20,000 42,900 -31.80 35.91 -718,260 1,540,668
2015-05-20 2015-05-18 4 XON INTREXON CORP
Option to Purchase Common Stock (Right to Buy)
M - Exercise -42,000 529,428 -7.35
2015-05-20 2015-05-18 4 XON INTREXON CORP
Option to Purchase Common Stock (Right to Buy)
M - Exercise -42,000 529,428 -7.35
2015-05-20 2015-05-18 4 XON INTREXON CORP
Common Stock
M - Exercise 42,000 42,000 7.12 299,040 299,040
2015-05-20 2015-05-18 4 XON INTREXON CORP
Common Stock
M - Exercise 42,000 42,000 7.12 299,040 299,040
2014-05-13 2014-05-09 4 XON INTREXON CORP
Common Stock
P - Purchase 20,900 20,900 14.21 297,022 297,022
2014-03-24 2014-03-20 4 XON INTREXON CORP
Option to Purchase Common Stock (Right to Buy)
A - Award 300,000 300,000
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)